Dicyclomine HCl

Dicyclomine HCl


 
Action  
Indications  
Contraindications  
Route/Dosage  
Interactions  
Lab Test Interferences  
Adverse Reactions  
Precautions
Patient Care Considerations  
Administration/Storage  
Assessment/Interventions  
Patient/Family Education

(die-SIGH-kloe-meen HIGH-droe-KLOR-ide) Antispas, Bemote, Bentyl, Byclomine, Dibent, Dilomine, Di-Spaz, Or-Tyl, Bentylol, Formulex Class: Anticholinergic; Antispasmodic

 Action Relieves smooth muscle spasm of GI tract through anticholinergic effects and direct action on GI smooth muscle.

 Indications Treatment of functional bowel/irritable bowel syndrome (irritable colon, spastic colon, mucous colitis). Unlabeled use(s): Intestinal colic in children > 6 mo.

 Contraindications Narrow angle glaucoma; adhesions between iris and lens; obstructive uropathy; obstructive disease of GI tract; paralytic ileus; intestinal atony of elderly or debilitated patient; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; hepatic or renal disease; tachycardia; myocardial ischemia; unstable cardiovascular status in acute hemorrhage; myasthenia gravis; infants < 6 mo.

 Route/Dosage

ADULTS: Initial dose: PO 80 mg/day in 4 equally divided doses. Increase to 160 mg/day in 4 equally divided doses. IM 80 mg/day in 4 divided doses.

 Interactions

Amantadine, tricyclic antidepressants: May cause increased anticholinergic side effects. Atenolol, digoxin: May increase pharmacologic effects of these drugs. Phenothiazines: May reduce antipsychotic effectiveness.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Palpitations; tachycardia. CNS: Headache; flushing; nervousness; drowsiness; weakness; dizziness; confusion; insomnia; fever (especially in children); mental confusion or excitement (especially in elderly, even with small doses); CNS stimulation (restlessness, tremor); lightheadedness. DERM: Severe allergic reactions including anaphylaxis, urticaria and dermal manifestations; local irritation following injection. EENT: Blurred vision; mydriasis; photophobia; cycloplegia; increased IOP; dilated pupils; nasal congestion. GI: Dry mouth; altered taste perception; nausea; vomiting; dysphagia; heartburn; constipation; bloated feeling; paralytic ileus. GU: Urinary hesitancy and retention; impotence. OTHER: Suppression of lactation; decreased sweating.

 Precautions

Pregnancy: Category B. Lactation: Excreted in breast milk. Children: Safety and efficacy have not been established. Contraindicated in infants < 6 mo. In infants, serious respiratory symptoms, seizures, syncope, pulse rate fluctuation, muscular hypotonia, coma and death have been reported. Elderly or debilitated patients: Elderly patients may react with excitement, agitation, drowsiness, and other untoward manifestations to even small doses. Special risk patients: Use with caution in patients with autonomic neuropathy, hyperthyroidism, hypertension, coronary heart disease, CHF, hiatal hernia, prostatic hypertrophy. Anticholinergic psychosis: Reported in sensitive individuals and may include confusion, disorientation, short-term memory loss, hallucinations, dysarthria, ataxia, coma, euphoria, decreased anxiety, fatigue, insomnia, agitation and mannerisms, and inappropriate affect. Diarrhea: May be symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy. Treatment of diarrhea with drug is inappropriate and possibly harmful. Gastric ulcer: May delay gastric emptying rate and complicate therapy. Heat prostration: Can occur in presence of high environmental temperature.


PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • For parenteral administration, give only intramuscularly. Drug is not for IV use.
  • Administer drug 30 min before meals.
  • Store in tightly closed container at room temperature and protect from light. Injection fluid should be clear.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess baseline vital signs.
  • Monitor I&O.
  • Ask patient if difficulty in voiding is a problem.
  • Assess hydration status (eg, skin turgor, mucous membranes, stool consistency, frequency) and bowel sounds.
  • Monitor patient for changes in vital signs and sensorium (eg, fever, tachycardia, confusion, anxiety).
OVERDOSAGE: SIGNS & SYMPTOMS   Circulatory failure, vomiting, abdominal distention, muscle weakness, anxiety, stupor, blurred vision, photophobia, dilated pupils, urinary retention

 Patient/Family Education

  • Instruct patient not to take any otc medications without consulting physician.
  • Advise contact lens wearers to use lubricating solutions.
  • Warn patients to avoid direct sunlight and any heat extremes (eg, exercise in hot weather, saunas, prolonged activity in hot weather).
  • Instruct patient to take sips of water frequently, suck on ice chips or sugarless hard candy or chew sugarless gum if dry mouth occurs.
  • Alert patients to pay special attention to fever, decreased ability to sweat and changes in bowel or bladder habits.
  • Advise elderly patients to report eye pain to physician or ophthalmologist and to undergo testing for glaucoma.
  • Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness.
  • Tell patient to report any difficulty in swallowing to physician.


Справочник препаратов (англ.) / D

Инфекционные болезни для всех
Женское здоровье
Инфекционные заболевания
Туберкулез
Хирургические болезни
Акушерство
Гинекология
Глазные болезни
Болезни уха, горла, носа
Стоматология
Кожные болезни
Венерические заболевания
Нервные болезни
Психические болезни
Детские болезни
Первая помощь
Хирургические болезни
Острые отравления
Лекарственные средства
Лабораторные анализы
Современные методы исследования
Уход за больными
Физио-терапевтические процедуры
Диетическое питание
Санаторно курортное лечение
Внутренние болезни

Это интересно